Literature DB >> 7542813

Influence of spontaneous portosystemic collateral pathways on portal hemodynamics in living-related liver transplantation in children. Doppler ultrasonographic study.

M Fujimoto1, F Moriyasu, T Nada, Y Suginoshita, Y Ito, K Nishikawa, H Someda, M Okuma, Y Inomata, N Ozaki.   

Abstract

We investigated the influence of spontaneous portosystemic collateral pathways on the portal hemodynamics and examined the necessity for ligating these vessels in pediatric liver transplantation from living donors. We assessed portal blood flow before, during, and after surgery in 82 pediatric recipients (mean age, 4.2 years), using Doppler ultrasonography. When blood flow in the reconstructed portal vein was decreased (< 10 ml/min/kg body weight) and portosystemic collaterals persisted during surgery, those vessels were ligated and Doppler flowmetry was examined again. Spontaneous portosystemic collaterals were detected at one or more sites in 67 patients before transplantation. These collaterals had been ligated in 17 patients before intraoperative flowmetry. Among the remaining 50 patients, initial Doppler studies revealed a decrease in portal blood flow in 22 patients. Nine patients had hepatofugal splenic venous flow and 6 had no significant flow signals from the intrahepatic portal vein. Ligation of collaterals resulted in a remarkable increase in portal blood flow in 20 patients, all of whom are alive. The remaining 2 patients died of graft failure due in part to portal hypoperfusion. On the other hand, the collaterals were not ligated in 24 patients because adequate portal blood flow was confirmed by intraoperative flowmetry. Postoperatively, flow signals from the unligated collateral vessels gradually diminished, but they still persisted in 3 patients at 12 months after transplantation. Hepatofugal blood flow through the portosystemic collateral pathways may persist after implantation of a normal graft. If the patent collaterals significantly reduce the effective portal blood flow, these vessels should be ligated in order to avoid graft failure.

Entities:  

Mesh:

Year:  1995        PMID: 7542813     DOI: 10.1097/00007890-199507150-00008

Source DB:  PubMed          Journal:  Transplantation        ISSN: 0041-1337            Impact factor:   4.939


  5 in total

1.  How to handle a huge portosystemic shunt in adult living donor liver transplantation with a small-for-size graft: report of a case.

Authors:  Yasumasa Shirouzu; Yuki Ohya; Yukika Tsukamoto; Hidekazu Yamamoto; Kwang-Jong Lee; Hideaki Okajima; Katsuhiro Asonuma; Yukihiro Inomata
Journal:  Surg Today       Date:  2009-06-28       Impact factor: 2.549

2.  Radiological anatomy of spontaneous splenorenal shunts in patients with chronic liver disease.

Authors:  Sachiko Achiwa; Shozo Hirota; Yasukazu Kako; Haruyuki Takaki; Kaoru Kobayashi; Koichiro Yamakado
Journal:  Jpn J Radiol       Date:  2017-03-01       Impact factor: 2.374

3.  Primary living-donor liver transplantation at the University of Chicago: technical aspects of the first 104 recipients.

Authors:  J M Millis; D C Cronin; L M Brady; K A Newell; E S Woodle; D S Bruce; J R Thistlethwaite; C E Broelsch
Journal:  Ann Surg       Date:  2000-07       Impact factor: 12.969

4.  Balloon-occluded retrograde transvenous obliteration is feasible for prolonged portosystemic shunts after living donor liver transplantation.

Authors:  Yoshihiro Nagao; Tomohiko Akahoshi; Hideo Uehara; Naotaka Hashimoto; Nao Kinjo; Hirofumi Kawanaka; Morimasa Tomikawa; Hideaki Uchiyama; Tomoharu Yoshizumi; Yuuji Soejima; Ken Shirabe; Yoshihiko Maehara
Journal:  Surg Today       Date:  2013-03-07       Impact factor: 2.549

5.  Ligation of huge spontaneous porto-systemic collaterals to avoid portal inflow steal in adult living donor liver transplantation: A case-report.

Authors:  Mohamed Elshobary; Ahmed Shehta; Tarek Salah; Ahmed Mohamed Sultan; Usama Shiha; Ahmed Nabieh Elghawalby; Ahmed Monier; Mohamed Elsadany; Omar Fathy; Mohamed Abdel Wahab
Journal:  Int J Surg Case Rep       Date:  2017-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.